Phase 2 Startpositive
Phase 2 Start: A Phase Ib Clinical Trial, Using Interleukin-2 (IL-2) and Semaglutide in Patients With Alzheimer's D
- Company
- GH Research PLC (GHRS)
- Drug
- interleukin-2
- Indication
- Alzheimer Dementia (AD)
Other upcoming events for GHRS
Phase 2 StartPhase 2 Start: A Randomized, Double-Blind, Phase 2, Efficacy and Safety Study of Allogeneic HB-adMSCs vs Placebo fo
Phase 2 StartPhase 2 Start: A Phase 1/2 Open-Label Intrathecal Administration of TSHA-105 to Determine the Safety and Efficacy i
Phase 2 StartPhase 2 Start: Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled
Phase 2 StartPhase 2 Start: MOZART MZL: A Randomized Phase II Study Evaluating Mosunetuzumab Alone and in Combination With Eithe
Phase 2 StartPhase 2 Start: A Phase II Randomized Study of Blinatumomab With or Without Revumenib for Patients With KMT2A-Transl
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.